Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BASE: Bronchiectasis Assessment of Severity and Exacerbations for Baseline Severity Classification and One-Year Exacerbation Risk Prediction in Non-Cystic Fibrosis Bronchiectasis

NCT07599839 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07599839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07599839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BASE: Bronchiectasis Assessment of Severity and Exacerbations for Baseline Severity Classification and One-Year Exacerbation Risk Prediction in Non-Cystic Fibrosis Bronchiectasis
Lead sponsor
Assiut University
Phase
Observational
Overall status
Recruiting
Start date
September 11, 2025
Completion date
February 1, 2027
Enrollment
750 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis, bronchiectasis with acute exacerbation, non-cystic fibrosis bronchiectasis